Lispro Is an Insulin Analogue Produced by Recombinant DNA Technology

question 9

Multiple Choice

Lispro is an insulin analogue produced by recombinant DNA technology. Which of the following statements about this form of insulin is NOT true?

• A) Optimal time of preprandial injection is 15 minutes.
• B) Duration of action is increased when the dose is increased.
• C) It is compatible with neutral protamine Hagedorn insulin.
• D) It has no pronounced peak.

---

Definitions:

Current Accounting Regulations

The prevailing rules and standards that govern how financial records are maintained and reported, varying by jurisdiction and overseen by regulatory bodies.

Non-current Assets

These are assets held for long-term use in a business, not expected to be converted into cash within one year, such as property, plant, and equipment.

Separate Disclosures

Financial statement notes or sections that provide additional detail on specific items not fully explained within the main financial statements.

Depreciation Expense Adjustment

Accounting practice of spreading out the cost of a tangible asset over its useful life.